Head mit Logo
Deutsch | English

Augenzentrum AG
Fährweg 10
CH-4600 Olten
beim Kantonsspital
Haus M/Eingang West/1.OG
Tel. +41 62 206 87 37
Fax +41 62 206 87 38


Functional and aesthetic outcome after bony lateral wall decompression with removal of the orbital rim and additional fat resection in graves’ orbitopathy with regard to the configuration of the lateral canthal region. Fichter N, Krentz H, Guthoff RF Orbit, submitted for publication.

Review article: Orbital decompression in thyroid eye disease. Fichter N; Guthoff RF, Schittkowski M. ISRN Ophthalmology, Volume 2012, Article ID 739236

Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' Orbitopathy. J Clin Endocrinol Metab. 2012 Dec;97(12):4454-63

Management der endokrinen Orbitopathie - Consensus statement der European Group on Graves‘ Orbitopathy (EUGOGO). Fichter N, von Arx G, Stahl M, Lareida J. Schweiz Med Forum 2012, 12(10): 225-29

Selenium and The Course of Mild Graves' Orbitopathy. European Group on Graves' Orbitopathy. N Engl J Med. 2011 May 19;364(20):1920-31

Glucocorticoid administration for Graves' hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association. J Endocrinol Invest. 2010 Jun;33(6):409-13

Graves' Orbitopathy - A Multidisciplinary Approach, Wiersinga WM, Kahaly GJ (Editors), Karger Publications, 2010(2), ISBN 978-3-8055-9531-5

Consensus statement der European Group on Graves‘ Orbitopathy (EUGOGO) zum management der endokrinen Orbitopathie. Fichter N, von Arx G, Stahl M, Lareida J. Ophta 2010; 6: 453-464.

Outcome of orbital decompression for disfiguring proptosis in patients with Graves’ Orbitopathy using various surgical procedures Br J Ophthalmol 2009;93:1518-1523

Proceedings of the 1st Swiss Symposium on Thyroid Eye Disease 2007, Editorial, Orbit 2009;28(4):209-213

Imaging in Graves' Orbitopathy. Orbit 2009;28(4):219-225

Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves' Orbitopathy - A pilot study at 1.5T. Neuroradiology 2009 Sept. 15 (Epub ahead of Print)

Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy, Thyroid, 2008 Mar;18(3):333-46

Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of GO, Eur J Endocrinol, 2008 Mar;158(3):273-85

Autogenous tarsus transplant as spacer for treatment of lower lid retraction in Graves disease. Schittkowski M, Fichter, N, Guthoff, R.F. Klin Monatsbl Augenheilkd 2008; 225:708-12

Clinical assessment of patients with Graves' Orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol. 2006 Sep;155(3):387-9

Laterale knöcherne Orbitadekompression bei Endokriner Orbitopathie. Indikation, Operationstechnik, Behandlungserfolg. Fichter N, Schittkowski M, Vick HP, Guthoff RF. Der Ophthalmologe 2004; 101: 339-349

Die Behandlung der Oberlidretraktion bei Endokriner Orbitopathie durch die Rücklagerung des Levatorkomplexes. Fichter N, Schittkowski M, Guthoff RF. Klin Monatsbl Augenheilkd 2004; 221: 933-940

Augenmuskeloperationen bei Endokriner Orbitopathie –Dosis-Wirkungs-Beziehung und funktionelle Ergebnisse. Schittkowski M, Fichter N, Guthoff RF. Klin Monatsbl Augenheilkd 2004; 221: 941-947